{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:48:04Z","timestamp":1782827284321,"version":"3.54.5"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2793","type":"journal-article","created":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T01:44:02Z","timestamp":1416015842000},"page":"2581-2583","source":"Crossref","is-referenced-by-count":5,"title":["One Year of Infliximab Therapy Successfully Improved a Case of Refractory Pouchitis without the Use of Antibiotics"],"prefix":"10.2169","volume":"53","author":[{"given":"Masahiro","family":"Iizuka","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Akita Red Cross Hospital, Japan"},{"name":"Akita Health Care Center, Akita Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Etou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Akita Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Yagisawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Akita Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Akita Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Sagara","sequence":"additional","affiliation":[{"name":"Akita Health Care Center, Akita Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Pardi DS, Sandborn WJ. Systematic review: the management of pouchitis. Aliment Pharmacol Ther 23: 1087-1096, 2006."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Madden MV, McIntyre AS, Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 39: 1193-1196, 1994.","DOI":"10.1007\/BF02093783"},{"key":"3","unstructured":"3. Molnar T, Farkas K, Nagy F, Wittmann T. Successful use of infliximab for treating fistulizing pouchitis with severe extraintestinal manifestation: a case report. Inflamm Bowel Dis 14: 1752-1753, 2008."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Viscido A, Habib FI, Kohn A, et al. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther 17: 1263-1271, 2003.","DOI":"10.1046\/j.1365-2036.2003.01535.x"},{"key":"5","unstructured":"5. Barreiro-de Acosta M, García-Bosch O, Souto R, et al. Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study. Inflamm Bowel Dis 18: 812-817, 2012."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Viazis N, Giakoumis M, Koukouratos T, et al. Long term benefit of one year infliximab administration for the treatment of chronic refractory pouchitis. J Crohns Colitis 7: e457-e460, 2013.","DOI":"10.1016\/j.crohns.2013.02.018"},{"key":"7","unstructured":"7. Barreiro-de Acosta M, García-Bosch O, Gordillo J, et al. Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series. Eur J Gastroenterol Hepatol 24: 756-758, 2012."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shiraki M, Yamamoto T. Efficacy of biologic therapy in patients with chronic pouchitis. Int J Colorectal Dis 28: 885, 2013.","DOI":"10.1007\/s00384-012-1546-z"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zippi M, Cassieri C, Avallone EV, Pica R. Infliximab for the treatment of pouchitis. World J Clin Cases 1: 191-196, 2013.","DOI":"10.12998\/wjcc.v1.i6.191"},{"key":"10","unstructured":"10. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 69: 409-415, 1994."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA 291: 827-835, 2004.","DOI":"10.1001\/jama.291.7.827"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rossini A, Rumio C, Sfondrini L, et al. Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice. Cancer Res 66: 6219-6224, 2006.","DOI":"10.1158\/0008-5472.CAN-05-4592"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Barrie A, Regueiro M. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 13: 1424-1429, 2007.","DOI":"10.1002\/ibd.20196"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/22\/53_53.2793\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:52:49Z","timestamp":1621446769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/22\/53_53.2793\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":13,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2793","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}